Literature DB >> 15602748

Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia.

S Thameem Dheen1, Yan Jun, Zhou Yan, Samuel S W Tay, Eng Ang Ling.   

Abstract

The release of proinflammatory mediators such as tumor necrosis factor-alpha (TNF-alpha) and nitric oxide by microglia has been implicated in neurotoxicity in chronic neurodegenerative diseases such as Alzheimer's disease. As all-trans-retinoic acid (RA) has been reported to exert anti-inflammatory actions in various cell types, we have examined its effects on the expression of TNF-alpha and inducible nitric oxide synthase (iNOS) in microglia activated by beta-amyloid peptide (Abeta) and lipopolysaccharide (LPS). Exposure of primary cultures of rat microglial cells to Abeta or LPS stimulated the mRNA expression level of TNF-alpha (6-116-fold) and iNOS (8-500-fold) significantly. RA acted in a dose-dependent manner (0.1-10 microM) by attenuating both TNF-alpha (29-97%) and iNOS (61-96%) mRNA expression in microglia exposed to Abeta or LPS. RA-induced inhibition of TNF-alpha and iNOS mRNA expression in activated microglia was accompanied by the concomitant reduction in release of iNOS and TNF-alpha proteins as revealed by nitrite assay and ELISA, respectively. The anti-inflammatory effects of RA were correlated with the enhanced expression of retinoic acid receptor-beta, and transforming growth factor-beta1 as well as the inhibition of NF-kappaB translocation. These results suggest that RA may inhibit the neurotoxic effect of activated microglia by suppressing the production of inflammatory cytokines and cytotoxic molecules. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15602748     DOI: 10.1002/glia.20153

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  61 in total

Review 1.  Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.

Authors:  Mrinmay Chakrabarti; Alexander J McDonald; J Will Reed; Melissa A Moss; Bhaskar C Das; Swapan K Ray
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 2.  Microglia as a pharmacological target in infectious and inflammatory diseases of the brain.

Authors:  R Bryan Rock; Phillip K Peterson
Journal:  J Neuroimmune Pharmacol       Date:  2006-06       Impact factor: 4.147

Review 3.  Inflammation and microglia actions in Alzheimer's disease.

Authors:  Colin K Combs
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-11       Impact factor: 4.147

4.  Bovine serum albumin promotes IL-1beta and TNF-alpha secretion by N9 microglial cells.

Authors:  Tian-zhi Zhao; Yong-zhi Xia; Lan Li; Jian Li; Gang Zhu; Shi Chen; Hua Feng; Jiang-kai Lin
Journal:  Neurol Sci       Date:  2009-08-21       Impact factor: 3.307

5.  9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes.

Authors:  Jihong Xu; Paul D Drew
Journal:  J Neuroimmunol       Date:  2005-11-21       Impact factor: 3.478

6.  Sinomenine inhibits microglial activation by Aβ and confers neuroprotection.

Authors:  Shilpa Mishra Shukla; Shiv K Sharma
Journal:  J Neuroinflammation       Date:  2011-09-14       Impact factor: 8.322

7.  Synaptic signaling by all-trans retinoic acid in homeostatic synaptic plasticity.

Authors:  Jason Aoto; Christine I Nam; Michael M Poon; Pamela Ting; Lu Chen
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

8.  Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.

Authors:  Yun Ding; Aimin Qiao; Ziqing Wang; J Shawn Goodwin; Eun-Sook Lee; Michelle L Block; Matthew Allsbrook; Michael P McDonald; Guo-Huang Fan
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

Review 9.  Towards retinoid therapy for Alzheimer's disease.

Authors:  K Shudo; H Fukasawa; M Nakagomi; N Yamagata
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

10.  Minocycline and sulforaphane inhibited lipopolysaccharide-mediated retinal microglial activation.

Authors:  Li-ping Yang; Xiu-an Zhu; Mark O M Tso
Journal:  Mol Vis       Date:  2007-07-09       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.